Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib monotherapy in chemo‑refractory metastatic melanoma
2007-002828-15Phase 2Active
- Sponsor
- Krankenhaus Nordwest
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in melanoma, sponsored by Krankenhaus Nordwest. Primary endpoint: Clinical benefit rate. Started Oct 2008; status: active.
02
Drugs
sunitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on 2007-002828-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002828-15.